Joseph Amankwaah MLS, PhD

Medical laboratory Scientist 👨‍🔬 || Cardiovascular Pathophysiologist

[Signal Transduction and Targeted Therapy (STTT) @sigtrans_sttt]

#STTT review : Adu-Amankwaah, J., Shi, Y., Song, H. et al. Signaling pathways and targeted therapy for pulmonary hypertension. Sig Transduct Target Ther 10, 207 (2025). https://t.co/X3iSa5spU2

[Joseph Amankwaah MLS, PhD @JosephAmank3]

🚨 Published in the world’s #1 Biochem & Mol Bio journal!
Our PH review is out in Signal Transduction & Targeted Therapy (IF: 52.7)!
📌 20+ pathways
📌 Gene & cell therapy
📌 Cell–cell interactions decoded
🔗 https://t.co/XBAu1leCfw
#PHResearch #CardioTwitter #STTT

[Philip Cardiff @phiiliipc]

Are you interested in working as a Postdoc with me at University College Dublin on developing finite volume methods for cardiovascular fluid-solid interaction simulations? Apply here (search for Job Ref 018140): https://t.co/XCSAbo1MeD

#jobfairy @UCD_Mech_Eng @ERC_Research

[Sean Davidson @SeanDavidsonHCI]

We have a postdoc position available at the Hatter Cardiovascular Institute, UCL. https://t.co/lPAFdOFLS2 #CardioResearch #ECR #job #postdocposition
@ISHR_ECI @IshrMci @BSCResearch @ISHR_ES

[Sean Davidson @SeanDavidsonHCI]

We have a postdoc position available at the Hatter Cardiovascular Institute, UCL. (link updated) https://t.co/5H9zW9hCcF #CardioResearch #ECR #job #postdocposition
@ISHR_ECI
@IshrMci
@BSCResearch
@ISHR_ES

[Rafail Kotronias @RafKotronias]

🚨 Interventional Cardiology Research Fellowship – Oxford 🚨

@GiovanniLuigiD1 & team are looking for passionate researchers to join their ambitious STEMI research program. A unique chance to contribute to cutting-edge research while pursuing funding for a research degree!

[Soehnlein Lab @soehnleinlab]

New #postdoc opportunity in our lab. The project centers on #neutrophils in #atherosclerosis and is a joint translational initiative with our parteners @novonordisk. https://t.co/i3ol8xnLEi

[APS Publications @APSPublications]

Gender differences in #GRK2 in #cardiovascular diseases and its interactions with #estrogen (Fu et al.) - new review in @AJPCell's Advances in GPCRs: Structure, Mechanisms, Disease, and Pharmacology collection

https://t.co/dp9sseyYzs

#cardiovasculardiseases #GPCR

[Joseph Amankwaah MLS, PhD @JosephAmank3]

@shattawalegh @shattawalegh Grow up!!

[Joseph Amankwaah MLS, PhD @JosephAmank3]

@kwadwosheldon Her: ‘after the relationship I’m going with my own head’ why the relationship ebe apprenticeship😂😂😂😂 #WKHKYD?

[Manasseh Azure Awuni @Manasseh_Azure]

My dear friend, please, this for you. Happy New Year.

[lindsaymalloy.bsky.social Dr. Lindsay Malloy @LMalloy]

My postdoc & I have had a manuscript under review for 9 months & today it was returned to us bc they said they were unable to find suitable reviewers.

Has this happened to anyone else? I’m completely shocked & frustrated.

[Frontiers in Cardiovascular Medicine @FrontCVMedicine]

New Research: The Synergy of ADAM17-Induced Myocardial Inflammation and Metabolic Lipids Dysregulation During Acute Stress: New Pathophysiologic Insights Into Takotsubo Cardiomyopathy: Due to its reversible nature, Takotsubo… https://t.co/j1EELjegz3 #cardiovascular

[Frontiers - Cell Biology @FrontCellDevBio]

New Research: Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency: Heart failure (HF) remains a public health concern… https://t.co/wvGB1okzZH #celldevbio

[Frontiers - Cell Biology @FrontCellDevBio]

New Research: ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress: Heart failure development is characterized by persistent inflammation and progressive fibrosis owing to… https://t.co/MmLwt3PRwC #celldevbio

[Joseph Amankwaah MLS, PhD @JosephAmank3]

The cardiovascular aspect of COVID-19 https://t.co/02RZePITTd

[BiykemBozkurt @BiykemB]

Join me in welcoming our #JACCHF #SoMe Editors @EiranGorodeski & @docbhardwaj and their outstanding team! @ersied727 @KevinShahMD @JTThibs @Nikhil15 @md_viviana @Abraham_Jacob @bhtrachtenberg officially starting in July. So excited! @JACCJournals #JACCHF

[Viviana Navas, MD @md_viviana]

“Happy heart syndrome”😃 vs “broken heart syndrome” 💔 is the pathophysiology the same? Then why is it more common in men and frequently presents with mid-ventricular ballooning? Outcomes the same..
https://t.co/0sRFYFWamh @JACCJournals #JACCHF #takotsubo

[Henry Han @HanCardiomd]

Happy Heart” Versus “Broken Heart” Syndrome: The 2 Faces of #Takotsubo Syndrome: Similarities and Differences∗

@JosephAmank3 https://t.co/YROvZ6fCSM @JACCJournals #JACCHF @mmamas1973 @AndrewJSauer @DrMarthaGulati @mirvatalasnag @aayshacader @NMHheartdoc @BiykemB

[Dr Andrew Mitchell @mitcharj]

“Happy Heart” Versus “Broken Heart” Syndrome: The 2 Faces of Takotsubo Syndrome: Similarities and Differences https://t.co/tIUz9seaip #cardiotwitter #takotsubo @JACCJournals